Orchestra BioMed Holdings Overview
Orchestra BioMed Holdings Discounted Cash Flow
DCF Analysis for OBIO.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.01
Current Fair Value
$-0.01
↓ 100.2% Downside
Overvalued by 100.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison